Connect with us


Cannabis-based sleep product sales up 635% since COVID-19



Cannabis shopping platform Ganja Goddess said the industry as a whole has shown signs of growth since the pandemic began

US sales of cannabis products that are marketed to help sleep, have increased significantly since the start of the pandemic as the industry continues to cultivate.

California’s online shopping, lifestyle and cannabis delivery platform, Ganja Goddess, announced key consumer and platform findings since the start of the COVID-19 this month.

The results revealed a sustained demand for cannabis delivery one year since the start of the global pandemic. 

Ganja Goddess’ key consumer and platform shifts include a 635 percent increase in revenue for cannabis products marketed to support sleep.

The industry as a whole saw a sustained 100 percent growth year-on-year, a 275 percent increase in revenue on 4/20, the largest day for cannabis delivery sales, shortly followed by a 200 percent increase in revenue on Cyber Monday, the second largest.

The platform also reported a 53 percent increase in conversion rates, which outperforms the average e-commerce conversion rate of one to two percent by more than 350 percent.  

During lockdown restrictions, both medical and recreational cannabis were considered essential services across the US, but were forced to shift to delivery or collection services. 

“With consumers spending more time at home than ever before while sheltering in place, cannabis delivery became a vital force in the industry,” said Ganja Goddess CEO Zachary Pitts.

“With cannabis deemed an essential service, the pandemic acted like rocket fuel for what was already a growing consumer trend headed for the mainstream. 

“In a year filled with challenges, we saw a surge in consumers placing orders for cannabis products marketed to help with sleep issues, highlighting one of the many health issues Americans are facing during the pandemic. 

Founded in 2011, Ganja Goddess offers statewide delivery services, online shopping and a curated online cannabis lifestyle experience that caters to consumers demands in California, the world’s largest cannabis market.

“The critical need for cannabis delivery remains at an all-time high. As challenges related to the pandemic continue, we are committed to serving the growing needs of cannabis consumers and patients across California.”

In the UK, research from a team at Southampton University found a sharp rise in the number of Britons suffering from insomnia and anxiety-induced sleep problems since the pandemic.

A paper published in the Journal of Psychopharmacology found that systemic acute administration of CBD appears to increase total sleep time and a review from 2017 echoed these sentiments, with researchers noting that preliminary research into CBD has found that CBD “may have therapeutic potential for the treatment of insomnia” and that it “may hold promise for REM sleep behaviour disorder and excessive daytime sleepiness”.

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag


Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2023 PP Intelligence Ltd.